- Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A). Ellsworth, J.L., Maurer, M., Harder, B., Hamacher, N., Lantry, M., Lewis, K.B., Rene, S., Byrnes-Blake, K., Underwood, S., Waggie, K.S., Visich, J., Lewis, K.E. J. Immunol. (2008)